A Phase 1 First-in-Human Study of Abbv-383, a BCMA × CD3 Bispecific T-Cell-Redirecting Antibody, As Monotherapy in Patients with Relapsed/Refractory Multiple Myeloma
| Autor: | Voorhees, Peter M., D'Souza, Anita, Weisel, Katja, Hurd, David Duane, Teipel, Raphael, Chung, Alfred, Rodriguez, Cesar, Tuchman, Sascha A., Korde, Neha, Safah, Hana, Bueno, Orlando F., Pumford, Neil, Rosenberg, Tanya S, Pothacamury, Rajvineeth Kumar, Ross, Jeremy A., Polepally, Akshanth R., Lee, Shane, Jin, Ziyi, Talati, Chetasi, Vij, Ravi, Kumar, Shaji K |
|---|---|
| Zdroj: | Blood; November 2022, Vol. 140 Issue: Supplement 1 p4401-4404, 4p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|